Back
ResMed Quote, Financials, Valuation and Earnings
Sponsored
RMD
Sponsored
My #1 Coin is...
All the details are on the next page.
Buy
52
RMD
ResMed
Last Price:
216.66
Seasonality Move:
6.4%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!ResMed Price Quote
$216.66
+3.78 (+1.78%)
(Updated: May 9, 2024 at 3:15 PM ET)
ResMed Key Stats
Buy
52
ResMed (RMD)
is a Buy
Day range:
$210.39 - $212.92
52-week range:
$132.24 - $237.26
Dividend yield:
0.9%
P/E ratio:
34.96
P/S ratio:
6.85
P/B ratio:
6.75%
Volume:
980.9K
Avg. volume:
1.2M
1-year change:
-8.52%
Market cap:
$31.3B
Revenue:
$4.2B
EPS:
$6.51
How Much Does ResMed Make?
Is ResMed Growing As A Company?
ResMed Stock Price Performance
What Is ResMed 52-Week High & Low?
ResMed Price To Free Cash Flow
-
Is ResMed Stock Overvalued?
ResMed is trading at a price to free cash flow ratio of 29.31 -
Is ResMed Stock Undervalued?
ResMed EV to Free Cash Flow ratio is 29.91 -
What Is ResMed’s Price Earnings Growth Ratio?
RMD PEG ratio is 3.00 -
Is ResMed Trading At A Premium To Earnings?
ResMed EV to EBIT ratio is 24.86
Is It Risky To Buy ResMed?
Is ResMed Cash Flow Positive?
ResMed Return On Invested Capital
ResMed Earnings Date & Stock Price
-
What Is ResMed's Stock Price Today?
A single share of RMD can be purchased today for 212.88 -
What Is ResMed’s Stock Symbol?
ResMed trades on the nyse under the ticker symbol: RMD -
When Is ResMed’s Next Earnings Date?
The next quarterly earnings date for ResMed is scheduled on August 2, 2024 -
When Is RMD's next ex-dividend date?
ResMed's next ex-dividend date is May 8, 2024 -
How To Buy ResMed Stock?
You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ResMed Competitors
ResMed Dividend Yield
ResMed Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 29.11% | 11.68% |
Revenue: | 7.17% | 2.12% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 0 |
Price Target: | 216.65 |
Upside from Last Price: | 1.77% |